311 related articles for article (PubMed ID: 1549953)
1. Stimulation of bone formation in osteoporosis patients treated with fluoride associated with increased DNA synthesis by osteoblastic cells in vitro.
Marie PJ; De Vernejoul MC; Lomri A
J Bone Miner Res; 1992 Jan; 7(1):103-13. PubMed ID: 1549953
[TBL] [Abstract][Full Text] [Related]
2. Decreased DNA synthesis by cultured osteoblastic cells in eugonadal osteoporotic men with defective bone formation.
Marie PJ; de Vernejoul MC; Connes D; Hott M
J Clin Invest; 1991 Oct; 88(4):1167-72. PubMed ID: 1918371
[TBL] [Abstract][Full Text] [Related]
3. Increased bone formation and osteoblastic cell phenotype in premature cranial suture ossification (craniosynostosis).
De Pollack C; Renier D; Hott M; Marie PJ
J Bone Miner Res; 1996 Mar; 11(3):401-7. PubMed ID: 8852951
[TBL] [Abstract][Full Text] [Related]
4. Age-related changes in bone formation, osteoblastic cell proliferation, and differentiation during postnatal osteogenesis in human calvaria.
de Pollak C; Arnaud E; Renier D; Marie PJ
J Cell Biochem; 1997 Jan; 64(1):128-39. PubMed ID: 9015761
[TBL] [Abstract][Full Text] [Related]
5. Bone cell responsiveness to transforming growth factor beta, parathyroid hormone, and prostaglandin E2 in normal and postmenopausal osteoporotic women.
Lomri A; Marie PJ
J Bone Miner Res; 1990 Nov; 5(11):1149-55. PubMed ID: 2176773
[TBL] [Abstract][Full Text] [Related]
6. Osteocalcin and deoxyribonucleic acid synthesis in vitro and histomorphometric indices of bone formation in postmenopausal osteoporosis.
Marie PJ; Sabbagh A; de Vernejoul MC; Lomri A
J Clin Endocrinol Metab; 1989 Aug; 69(2):272-9. PubMed ID: 2787799
[TBL] [Abstract][Full Text] [Related]
7. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment with low doses of norethindrone potentiates the osteogenic effects of fluoride on human osteosarcoma cells.
Takada J; Baylink DJ; Lau KH
J Bone Miner Res; 1995 Oct; 10(10):1512-22. PubMed ID: 8686507
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts.
Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R
Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687
[TBL] [Abstract][Full Text] [Related]
10. Effect of fluoride on bone and bone cells in ovariectomized rats.
Modrowski D; Miravet L; Feuga M; Bannié F; Marie PJ
J Bone Miner Res; 1992 Aug; 7(8):961-9. PubMed ID: 1442210
[TBL] [Abstract][Full Text] [Related]
11. Effects of methotrexate on human osteoblasts in vitro: modulation by 1,25-dihydroxyvitamin D3.
Scheven BA; van der Veen MJ; Damen CA; Lafeber FP; Van Rijn HJ; Bijlsma JW; Duursma SA
J Bone Miner Res; 1995 Jun; 10(6):874-80. PubMed ID: 7572311
[TBL] [Abstract][Full Text] [Related]
12. 1,25-dihydroxyvitamin D3-mediated transforming growth factor-beta release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiencies.
Sterck JG; Klein-Nulend J; Burger EH; Lips P
J Bone Miner Res; 1996 Mar; 11(3):367-76. PubMed ID: 8852947
[TBL] [Abstract][Full Text] [Related]
13. In vitro exposure to sodium fluoride does not modify activity or proliferation of human osteoblastic cells in primary cultures.
Chavassieux P; Chenu C; Valentin-Opran A; Delmas PD; Boivin G; Chapuy MC; Meunier PJ
J Bone Miner Res; 1993 Jan; 8(1):37-44. PubMed ID: 8427047
[TBL] [Abstract][Full Text] [Related]
14. In vitro expression of osteoblastic markers in cells isolated from normal fetal and postnatal human bone and from bone of patients with osteogenesis imperfecta.
Mörike M; Schulz M; Brenner RE; Bushart GB; Teller WM; Vetter U
J Cell Physiol; 1993 Dec; 157(3):439-44. PubMed ID: 8253854
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation.
Fromigué O; Marie PJ; Lomri A
J Cell Biochem; 1998 Mar; 68(4):411-26. PubMed ID: 9493905
[TBL] [Abstract][Full Text] [Related]
16. Fluoride modification effects on osteoblast behavior and bone formation at TiO2 grit-blasted c.p. titanium endosseous implants.
Cooper LF; Zhou Y; Takebe J; Guo J; Abron A; Holmén A; Ellingsen JE
Biomaterials; 2006 Feb; 27(6):926-36. PubMed ID: 16112191
[TBL] [Abstract][Full Text] [Related]
17. Osteoblast dysfunction in male idiopathic osteoporosis.
Pernow Y; Granberg B; Sääf M; Weidenhielm L
Calcif Tissue Int; 2006 Feb; 78(2):90-7. PubMed ID: 16467976
[TBL] [Abstract][Full Text] [Related]
18. Ultrahigh molecular weight polyethylene particles have direct effects on proliferation, differentiation, and local factor production of MG63 osteoblast-like cells.
Dean DD; Schwartz Z; Blanchard CR; Liu Y; Agrawal CM; Lohmann CH; Sylvia VL; Boyan BD
J Orthop Res; 1999 Jan; 17(1):9-17. PubMed ID: 10073642
[TBL] [Abstract][Full Text] [Related]
19. Picomolar norethindrone in vitro stimulates the cell proliferation and activity of a human osteosarcoma cell line and increases bone collagen synthesis without an effect on bone resorption.
Lau KH; Wang SP; Linkhart TA; Demarest KT; Baylink DJ
J Bone Miner Res; 1994 May; 9(5):695-703. PubMed ID: 8053399
[TBL] [Abstract][Full Text] [Related]
20. Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia.
Marie PJ; de Pollak C; Chanson P; Lomri A
Am J Pathol; 1997 Mar; 150(3):1059-69. PubMed ID: 9060842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
